Find a Doctor
Talk to Doctor
Make an Appointment
Medical Traveler Guide
Rezum Water Vapor Therapy – Innovative Treatment for Benign Prostatic Hyperplasia – No Surgery RequiredRead More
Combination of CRS and HIPEC offers Effective Treatment and Higher Chance of Survival for patients with Peritoneal MetastasesRead More
Crucial Health Screenings Women Should Prioritize Scheduling on a Regular BasisRead More
Treatment Methods for Rotator Cuff TearsRead More
Specialty :
DR. VIGROM JENNETISIN
SPECIALTY :
- Oncology
DR. VIGROM JENNETISIN
Educations (with year)
2012
- Fellowship of Medical Oncology, Ramathibodi Hospital, Mahidol University, 2012
2010
- Residency of Internal Medicine, Khonkaen Hospital, Khonkaen University, 2010.
2007
- Doctor of Medicine, Khonkaen University
Board Certifications
2020
- Certificate of Achievement: HMX Pro Cancer Genomics and Precision Oncology, Harvard Medical School
- Certificate of Achievement: HMX Pro Immuno-Oncology, Harvard Medical School
2019
- Certificate of Achievement: HMX Fundamentals – Genetics, Harvard Medical School
- Certificate of Achievement: HMX Fundamentals – Immunology, Harvard Medical School
Special Clinical Trainings
- Cancer Genomics and Precision Oncology
- Immuno Oncology / Immune Cell therapy / Cancer vaccine
Special Clinical Interests
- Advanced Technology in Cancer Omics (Multi omics approach)
- Personalized cancer treatment / Precision cancer medicine
Conditions Treated (Disease)
- All Solid malignancies : Breast cancer, Lung cancer, Colon cancer, Hepatobiliary cancer etc.
Publications
- A phase II single-center study of the tolerability and efficacy of TBX-3400 in subjects with chronic HBV or hepatitis virus associated liver tumors resistant or refractory to standard therapies. (Principle Investigator)
- Development of patient – derived organoids with accompanying molecular and anti- cancer drug response data for precision oncology. (Co-Investigator)
- Development of AI-assisted software for holistic need assessment in cancer patients to promote individualized cancer care. (Principle Investigator)
- Identification of Immunogenic Personal Tumor-Specific Mutations and Neoantigens from Solid tumor or Liquid biopsy (Principle investigator)
- Personalized neoantigen peptide vaccine for cancer treatment (Principle investigator)
Journal Affiliations
2016
- Correlation of Mitotic Index and Ki-67 and Their Impacts on Survival of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at Ramathibodi Hospital. Annals of Oncology, Volume 27, Supplement 2, June 01, 2016. Poster Presentation at ESMO World GI Congress, Barcelona, Spain.
2014
- Prevalence and risk factors for deep vein thrombosis in hospitalized high-risk patients at a tertiary care hospital in Thailand. Asian Biomedicine Vol.8 No.6, December ; 759 – 762
Professional Membership
- ASCO member since 2012
- ESMO member since 2012
- TSCO member since 2012
Clinic Hours
Patient Stories
Videos
Call us at
(+66)8-522 38888
Please select your language